Clinical Trial

Antagonism of Neostigmine in Continuous Infusion of Mivacurium

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 13, 2026 (before its estimated July 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
In this study, the antagonism of neostigmine, a cholinesterase inhibitor, on continuous infusion of mivacurium during foot and ankle surgery under general anesthesia was investigated, and the appropriate time point of antagonism was explored.
Trial Details
NCT Number NCT07524959
Lead Sponsor Beijing Tongren Hospital
Conditions Neuromuscular Blocking Agents
Enrollment 120 participants
Start Date 2026-05-01
Primary Completion 2026-07-20 (estimated)
Study Completion 2026-07-29 (estimated)
Updated on ClinicalTrials.gov 2026-04-13